Federal drug regulators have granted approval for a first-of-its-kind blood test that can detect intellectual disabilities in infants by scanning variations in patients’ chromosomes that are linked to many developmental disorders. The laboratory test, known as CytoScan Dx Assay is made by medical technology company Affymetrix. It is the first FDA-approved test that analyzes the whole genome in a single procedure at very high resolutions. An intellectual disorder is a condition in which a person has limitations in mental functioning and skills such as communicating, taking care of him- or herself, and social skills. These limitations will cause a child ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.